Upgrade to SI Premium - Free Trial

NKGen Biotech (NKGN)

0.19 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (1/9/26 *Est.)

Latest Headlines

Form 8-K NKGen Biotech, Inc. For: May 27 June 2, 2026 5:20 PM - SEC Filing Form 8-K NKGen Biotech, Inc. For: May 15 May 21, 2026 5:20 PM - SEC Filing NKGen Biotech Expands Clinical Trial Site Network for Alzheimer’s Disease Program Across U.S. to Improve Patient Access and Support Enrollment May 19, 2026 8:05 AM - Globe NewsWire Form 8-K NKGen Biotech, Inc. For: Apr 28 May 4, 2026 5:25 PM - SEC Filing Form 8-K NKGen Biotech, Inc. For: Apr 15 April 21, 2026 5:20 PM - SEC Filing NKGen Biotech to Present Troculeucel Mechanism Data in Alzheimer’s and Frontotemporal Dementia at the Neuroimmunology Drug Development Summit April 9, 2026 8:05 AM - Globe NewsWire NKGen Biotech reports cognitive improvements in Alzheimer's trial March 23, 2026 8:05 AM - StreetInsider NKGen Biotech Reports Combined Phase 1 Troculeucel Data Demonstrating Dose-Responsive Cognitive Improvements and Biomarker Correlations in Alzheimer’s Disease at AD/PD 2026™ March 23, 2026 8:05 AM - Globe NewsWire Full Article List